MTOR and leukemia: The cytotoxic mechanisms of CYT997 in leukemia cells were also investigated, with a particular focus on its effect on the cyclin-dependent kinase (cdc2) pathway, which regulates the entry of cells into mitosis, and the inhibition of PI3K/Akt/mTOR pathway proteins.